These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32550690)

  • 1. Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions.
    Schachner LA; Torrelo A; Grada A; Micali G; Kwong PC; Scott GB; Benjamin L; Gonzalez ME; Andriessen A; Eberlein T; Eichenfield LF
    J Drugs Dermatol; 2020 Mar; 19(3):281-290. PubMed ID: 32550690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Impetigo and Antimicrobial Resistance.
    Schachner LA; Lynde CW; Kircik LH; Torrelo A; Hohl D; Kwong P; Oza V; Andriessen A; Hebert AA
    J Drugs Dermatol; 2021 Apr; 20(4):366-372. PubMed ID: 33852242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
    J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
    Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
    J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.
    D'Cunha NM; Peterson GM; Baby KE; Thomas J
    J Clin Pharm Ther; 2018 Feb; 43(1):150-153. PubMed ID: 29063621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International comparison of guidelines for management of impetigo: a systematic review.
    Hall LM; Gorges HJ; van Driel M; Magin P; Francis N; Heal CF
    Fam Pract; 2022 Jan; 39(1):150-158. PubMed ID: 34184743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP's management of impetigo.
    Heal C; Gorges H; van Driel ML; Tapley A; Davis J; Davey A; Holliday L; Ball J; Najib N; Spike N; FitzGerald K; Magin P
    BMJ Open; 2019 Oct; 9(10):e031527. PubMed ID: 31662391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ideal Features of Topical Antibiotic Therapy for the Treatment of Impetigo: An Italian Expert Consensus Report.
    Neri I; Miraglia Del Giudice M; Novelli A; Ruggiero G; Pappagallo G; Galli L
    Curr Ther Res Clin Exp; 2023; 98():100690. PubMed ID: 36712177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of impetigo: oral antibiotics most commonly prescribed.
    Bolaji RS; Dabade TS; Gustafson CJ; Davis SA; Krowchuk DP; Feldman SR
    J Drugs Dermatol; 2012 Apr; 11(4):489-94. PubMed ID: 22453587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial resistance and impetigo treatment trends: a review.
    Bangert S; Levy M; Hebert AA
    Pediatr Dermatol; 2012; 29(3):243-8. PubMed ID: 22299710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for impetigo.
    Koning S; Verhagen AP; van Suijlekom-Smit LW; Morris A; Butler CC; van der Wouden JC
    Cochrane Database Syst Rev; 2004; (2):CD003261. PubMed ID: 15106198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric impetigo: an expert panel opinion about its main controversies.
    Galli L; Novelli A; Ruggiero G; Stefani S; Fortina AB
    J Chemother; 2022 Sep; 34(5):279-285. PubMed ID: 34405763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ozenoxacin: a review of preclinical and clinical efficacy.
    Vila J; Hebert AA; Torrelo A; López Y; Tato M; García-Castillo M; Cantón R
    Expert Rev Anti Infect Ther; 2019 Mar; 17(3):159-168. PubMed ID: 30686133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative review of current topical antibiotics for impetigo.
    Galindo E; Hebert AA
    Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of impetigo.
    Cole C; Gazewood J
    Am Fam Physician; 2007 Mar; 75(6):859-64. PubMed ID: 17390597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impetigo incidence and treatment: a retrospective study of Dutch routine primary care data.
    Loadsman MEN; Verheij TJM; van der Velden AW
    Fam Pract; 2019 Jul; 36(4):410-416. PubMed ID: 30346521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper.
    Rzewuska M; Charani E; Clarkson JE; Davey PG; Duncan EM; Francis JJ; Gillies K; Kern WV; Lorencatto F; Marwick CA; McEwen J; Möhler R; Morris AM; Ramsay CR; Rogers Van Katwyk S; Skodvin B; Smith I; Suh KN; Grimshaw JM;
    Clin Microbiol Infect; 2019 Feb; 25(2):163-168. PubMed ID: 30195471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating impetigo in primary care.
    Drug Ther Bull; 2007 Jan; 45(1):2-4. PubMed ID: 17367045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Metrics for Antimicrobial Stewardship Programs.
    Science M; Timberlake K; Morris A; Read S; Le Saux N;
    Pediatrics; 2019 Apr; 143(4):. PubMed ID: 30926619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Treatment Strategies for Impetigo in Endemic and Nonendemic Settings: A Systematic Review.
    Gahlawat G; Tesfaye W; Bushell M; Abrha S; Peterson GM; Mathew C; Sinnollareddy M; McMillan F; Samarawickrema I; Calma T; Chang AY; Engelman D; Steer A; Thomas J
    Clin Ther; 2021 Jun; 43(6):986-1006. PubMed ID: 34053699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.